ARTICLE | Financial News
Vivo Capital closes new early stage fund
June 14, 2016 1:14 AM UTC
Vivo Capital closed its new Vivo Panda fund with more than $100 million to invest primarily in early stage healthcare companies, including biotech, medtech and diagnostics. ...